Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
Summary
This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future
Arms & interventions
- OtherNo intervention
Observational study
Outcome measures
Primary
Rates of cervical cancer screening and endometrial sampling in TGD individuals
Describe the rates of cervical cancer screening and endometrial sampling in TGD individuals undergoing hysterectomy in the MHealth Fairview System between January 2014-June 2024.
Time frame: Month 36
Whether HPV self-testing affects the rates of cervical cancer screening in TGD individuals
Describe the rates of cervical and endometrial cancer and their precursor lesions on pathology after hysterectomy that was undiagnosed prior to hysterectomy in TGD individuals in the MHealth Fairview System between January 2014-June 2024.
Time frame: Month 36
Secondary
how introducing the option of HPV self-testing affects the rates of cervical cancer screening in TGD individuals undergoing hysterectomy.
Time frame: Month 36
how introducing the option of HPV self-testing affects patient experience
Time frame: Month 36
Eligibility criteria
Study locations (1)
University of Minnesota
Minneota, Minnesota, 55455